Nebula Research & Development’s Medifast MED Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-9,617	Closed	-$369K	–	948
2024 Q1	$369K	Buy	+9,617	New	+$369K	0.08%	461
2023 Q3	–	Sell	-2,626	Closed	-$242K	–	588
2023 Q2	$242K	Buy	+2,626	New	+$242K	0.18%	239